4-(Trifluoromethoxy)phenylmagnesium bromide solution

• Catalog No.: 687901
• M. F.: C7H4BrF3MgO
• M. W.: 265.3102696

SYNONYMS

• Title: 4-(三氟甲氧基)苯基溴化镁
• IUPAC name: bromo[4-(trifluoromethoxy)phenyl]magnesium
• IUPAC Traditional name: bromo[4-(trifluoromethoxy)phenyl]magnesium

DATABASE IDS

• MDL Number: MFCD09842767

PROPERTIES

• Concentration: 0.5 M in THF
• Empirical Formula (Hill Notation): C7H4BrF3MgO
• Density: 0.975 g/mL at 25 °C
• Flash Point: -30 - -20 °C
• Flash Point: -22 - -4 °F
• GHS Signal Word: Danger
• GHS Hazard statements: H225-H314-H335
• European Hazard Symbols: Flammable (F)
• European Hazard Symbols: Corrosive (C)
• GHS Precautionary statements: P210-P261-P280-P305 + P351 + P338-P310
• RID/ADR: UN 2924 3/PG 2
• Risk Statements: 11-14-19-34-37
• Safety Statements: 16-26-36/37/39-45
• Supplemental Hazard Statements: May form explosive peroxides., Reacts violently with water.
• Hazard Class: 3
• UN Number: 2924
• Packing Group: 2
• German water hazard class: 3

DETAILS

Description (English)

Packaging
50 mL in Sure/Seal™
Application
Reactant for:
• Preparation of chromanol derivatives as novel class of CETP inhibitors for treatment of cardiovascular disease1
• Pd-catalyzed cross coupling2
• Preparation of indazole-pyridine derivatives as protein kinase B/Akt inhibitors with reduced hypotension, via Stille coupling, Mitsunobu reaction and copper-catalyzed aziridine ring-opening reaction3

Description (简体中文)

包装
50 mL in Sure/Seal™
Application
Reactant for:
• Preparation of chromanol derivatives as novel class of CETP inhibitors for treatment of cardiovascular disease1
• Pd-catalyzed cross coupling2
• Preparation of indazole-pyridine derivatives as protein kinase B/Akt inhibitors with reduced hypotension, via Stille coupling, Mitsunobu reaction and copper-catalyzed aziridine ring-opening reaction3